Skip to main content
Erschienen in:

Open Access 10.06.2024 | Original Article

The usefulness of combined analysis using CIScore and VSRAD parameters for differentiating between dementia with Lewy body and Alzheimer’s disease

verfasst von: Gaku Honda, Shigeki Nagamachi, Mai Takahashi, Yukie Higuma, Tomonobu Tani, Kosuke Hida, Kengo Yoshimitsu, Koji Ogomori, Yoshio Tsuboi

Erschienen in: Japanese Journal of Radiology | Ausgabe 10/2024

Abstract

Purpose

The Cingulate Island score (CIScore) is useful index for differentiating between dementia with Lewy body (DLB) and Alzheimer’s disease (AD) using regional cerebral blood flow (rCBF) SPECT. The Z score standing for medial temporal lobe (MTL) atrophy and the ratio of Z score between dorsal brain stem (DBS) to MTL are useful indices for differentiating between DLB and AD using MRI with VSRAD. The current study investigated the diagnostic ability by the combined use of rCBF SPECT and MRI in the differentiation between AD and DLB.

Materials and methods

In cases with 42 AD and 28 DLB undertaken Tc-99m-ECD SPECT and MRI, we analyzed differential diagnostic ability between AD and DLB among following conditions by single or combined settings. Namely, they were (1) the CIScore as a parameter of rCBF SPECT (DLB ≦ 0.25), (2) Z score value of MTL atrophy (DLB ≦ 2.05), (3) the ratio of Z score of DBS to medial temporal gray matter as a parameter of brain atrophy using VSRAD (DLB ≧ 0.38). Also, we analyzed them both including and omitting the elderly (over 75 years old).

Results

The accuracy of differential diagnosis in this condition was 74% for (1), 69% for (2), and 67% for (3). The accuracy by combination condition was 84% for (1) and (2), 81% for (1) and (3), and 67% for (2) and (3), respectively. The combination method by CIScore and the Z score of MTL showed the best accuracy. When we confined condition to ages younger than 75 years, the accuracy improved to 94% in the combination method.

Conclusion

The combined use of CIScore and Z score of MTL was suggested to be useful in the differential diagnosis between DLB and AD particularly in younger than 75 years old.

Background

Both Alzheimer’s disease (AD) and dementia with Lewy bodies (DLBs) are main two dementia with high incidence rate and their increase is social problem in the worldwide [1]. Because many commonly used medications produce severe side effects in patients with DLB, such as medications with anticholinergic or antidopaminergic actions, without the correct differential diagnosis [2].
Although both amyloid positron emission tomography (PET) and Tau PET have emerged as powerful diagnostic tools [35], these modalities are only available in larger, specialized hospitals and research centers. In addition, there are rigorous of insurance coverage for amyloid PET, and it is not performed in still in all suspected AD cases. On the other hand, FDG-PET serves as a valuable tool for measuring brain glucose metabolism, enabling the differentiation of conditions by assessing hypometabolism in the occipital lobe in DLB [6, 7]. Additionally, regional cerebral blood flow (rCBF) SPECT offers a more convenient and practical imaging method suitable for actual clinical settings [8, 9].
The volumetric MRI is extensively used to diagnose AD using the patterns of cerebral atrophy, involving the medial temporal lobe (MTL) and temporoparietal association cortices [10]. In Japan, MRI is used more often than SPECT in many hospitals.
In the differential diagnosis between DLB and AD rCBF SPECT analysis of both posterior-cingulate gyri and occipital lobes is useful, which is known as the Cingulate Island Sign score (CIScore) [1113]. Although the sign is originally reported by FDG-PET [14], it is also widely used in routine clinical practice by rCBF SPECT examination recently, and the usefulness is confirmed [11]. The diagnostic ability of CIScore is known to be higher in conditions without influence of brain atrophy by aging [13].
In MRI, the Z score standing for MTL atrophy and the ratio of Z score between dorsal brain stem (DBS) CBF to MTL are useful indices for differentiating between DLB and AD using VSRAD [10]. The atrophic change in MTL is prominently noted in AD compared to DLB, and DBS is significantly noted in DLB compared to AD [10].
Thus, there are many reports regarding the diagnostic ability between DLB and AD when using each modality, VSRAD or CIScore, respectively [1014]. However, to the best of our knowledge, no studies by combined use of these parameters have been reported. In the current study, we investigated which method is the best differential diagnostic ability between DLB and AD, among CIScore, the Z score of MTL and the ratio of Z score between dorsal brainstem to MTL, and the combination of these indexes. We also investigated whether the combination of the CIScore and the MRI Z score contributed to improving the differential diagnostic ability.

Methods

Subjects

Twenty-eight cases with DLB and 42 cases with AD were analyzed retrospectively. All cases were diagnosed by neurologists and there were no organic lesions such as cerebrovascular lesions. As for DLB, all cases were diagnosed as probable DLB based on the diagnostic criteria advocated by the 4th International Workshop [2]. The cases with AD were analyzed by the diagnostic criteria based on National Institute of Neurologic, Communicative Disorders and Stroke AD and Related Disorders Association (NINCDS-ADRDA) research group [15]. All patients were undertaken three-dimensional T1-weighted MRI using 1.5-T MRI scanners within 4 weeks before or after Tc-99m-ECD SPECT studies.

SPECT and eZIS examination

All cases were undertaken Tc-99m-ECD SPECT, and all taken data were retrospectively analyzed statistically using easy Z score Imaging System (eZIS) (PDR radiopharma Inc. Tokyo, Japan) [16].
All SPECT scans were performed using a triple-headed gamma camera (GCA9300R; Canon Medical Systems Corp., Otawara City, Japan) and high-resolution fan-beam collimator. SPECT images were obtained with a 128 × 128 matrix and continuous repetitive data acquisition mode with 120° Rotation, acquisition time was 16 min (3 detector, 30 view/detector, 4repeat 2cycle/repeat, time/cycle 120 s). For SPECT image reconstruction, a Butterworth filter (cutoff frequency, 0.76 cycles/cm; order, 4) was used. Attenuation correction was performed using Chang’s method (µ = 0.15/cm) and scatter correction was performed with a triple energy window (TEW).
After the eZIS analysis, we computed the CIScore [12, 13]. This program also allows statistical parametric mapping results to be incorporated into an automated analysis of the Z score values in the volume of interest (VOI). Using eZIS program, two VOIs were set automatically on the posterior cingulate gyrus (VOI-1) and on the occipital lobe (VOI-2). The CIScore is defined as the ratio of the VOI-2 to the VOI-1, which is automatically calculated.

MRI and VSRAD examination

In the present study, 3-dimensional T1-weighted sagittal images were taken with an Intera Achieva 1.5 Tesla (Philips, Tokyo, Japan) under the following setting: FOV 240, matrix 256 × 256, slice thickness 1.2 mm, 220 slices, TR 10 ms, TE 5 ms, flip angle 25°.
VSRAD, we assessed brain atrophy in local gray matter or white matter was a free software designed to evaluate relative local brain volume of individual patients comparing with brain MRI database for healthy individuals by means of voxel-based morphometry (VBM) [10]. Using this program, the entire brain by 3-demensional T1-weighted image taken with a 1.5-Tesla MRI device is processed with SPM8 (Statistical Parametric Mapping, 2008 Edition) to isolate grey matter based on the anatomical standardization followed by statistical analysis of grey matter density.
The results of analysis are displayed as a colored scale map on the standard brain. These Z-score maps were displayed by overlay on tomographic sections and surface rendering of the standardized brain. We registered target VOIs in the MTL and DBS as specifically atrophied areas in AD and DLB, respectively, according to previous studies [10, 17].

Description of present method and data analyses

First, we computed the CIScore. Although the threshold value is 0.281 in the default setting, 0.26 was the best cut-off value from our receiver operating characteristic (ROC) analysis in the current study of our institute. Thus, we diagnosed as DLB in case with CIScore is 0.260 or less. Then, we calculated the differential diagnostic ability (Sensitivity: Sen, Specificity: Spe, Accuracy: ACC) of CIscore.
Second, we evaluated the Z score of the volumes of interest using VSRAD. The obtained data were analyzed using software VSRAD advance® on a PC. By the result of ROC analysis in the present study, the threshold values were determined. Namely in MTL, we diagnosed as DLB in case with the Z score is 2.06 or less. As for the ratio of Z score in DBS (gray matter) to MTL, we diagnosed as DLB in case with the value is 0.37 or more. Regarding the ratio of Z score in DBS (white matter) to MTL, we diagnosed as DLB in case with the value is 0.42 or more. Then, we calculated the differential diagnostic ability (Sen, Spe, ACC) by the Z score of MTL and by DBS.
Namely, each parameter and diagnostic criteria were as follows.
(1)
CIScore as a parameter of rCBF SPECT, we diagnosed as DLB in case which is 0.259 or less.
 
(2)
Z score value of MTL atrophy by MRI, we diagnosed as DLB in case which is 2.05 or less.
 
(3)
The atrophic ratio of dorsal brainstem to medial temporal gray matter (DBS) by MRI, we diagnosed as DLB in case which is 0.38 or more.
 
(4)
The atrophic ratio of dorsal brainstem to medial temporal white matter (DBS) by MRI, we diagnosed as DLB in case which is 0.42 or more.
 
Finally, we compared the clinical parameters and differential diagnostic ability among the single parameter and the combination of these parameters, including and omitting the elderly (over 75 years old). The clinical parameters were statistically evaluated by unpaired t test or chi-square test. The diagnostic accuracy was statistically evaluated using McNemar test. All statistical analyses were performed using StatFlex version 7 (Artek Osaka Japan).

Results

The mean values of Mini-Mental State Examination (MMSE) and age were significantly higher in DLB group compared to those in AD group in the comparison of the clinical parameters. There was no statistical significance in gender and duration of diseases among subgroup (Table 1). These results were similar when the elderly cases were excluded (Table 2).
Table 1
Comparison of clinical parameters
 
DLB (n = 28)
AD (n = 42)
P value
Age
77.3 ± 6.4
73.5 ± 8.0
0.04
Gender (M:F)
8:20
12:30
NS
MMSE
23.5 ± 4.9
20.2 ± 4.5
0.007
Duration of disease (years) ≦ 5/6–10/ ≧ 10
17/6/5
27/7/8
NS
Table 2
Comparison of clinical parameters in the cases of younger cases (< 75 years)
 
DLB (n = 11)
AD (n = 20)
P value
Age
70.5 ± 5.5
66.9 ± 6.2
0.03
Gender (M:F)
3:8
6:14
NS
MMSE
24.3 ± 4.0
19.3 ± 5.2
0.007
Duration of disease (years) ≦5/6–10/ ≧ 10
6/3/2
15/3/2
NS
The differential diagnosis abilities of the single parameter, by CIScore was, Sen 93%, Spe 62% and ACC 74%, respectively. Similarly, Sen 93%, Spe 52% and ACC 69% by MTL, Sen 79%, Spe 60% and ACC 67% by DBS (gray matter) (Table 3). In the conditions excluding elderly cases, CIScore was, Sen 100%, Spe 65% and ACC 77%, respectively. Similarly, Sen 100%, Spe 50% and ACC 68% by MTL, Sen 100%, Spe 45% and ACC 65% by DBS (gray matter) (Table 4).
Table 3
Comparison of differential diagnostic ability (single parameter)
 
Sensitivity
Specificity
Accuracy
CIScore
0.93
0.62
0.74
Z score of MTL
0.93
0.52
0.69
Atrophic ratio
0.79
0.60
0.67
Table 4
Comparison of differential diagnostic ability (single parameter, excluding the elderly)
 
Sensitivity
Specificity
Accuracy
CIScore
1
0.65
0.77
Z score of MTL
1
0.5
0.68
Atrophic ratio
1
0.45
0.65
When we diagnosed by the combination of these parameters, the sensitivity was 89% in condition with (1) and (2), 79% for (1) and (3), and 75% for (2) and (3), the specificity was 81% in condition with (1) and (2), 83% for (1) and (3), and 62% for (2) and (3), the accuracy was 84% for (1) and (2), 81% for (1) and (3), and 67% for (2) and (3) (Table 5). The combination method of CIScore and Z score value of MTL atrophy showed the best accuracy. When we used this combination method and omitting the elderly, the accuracy was 94% for (1) and (2), 90% for (1) and (3), and 68% for (2) and (3) (Table 6). The accuracy of all combination of these parameters improved when we excluded the elderly (over 75 years old).
Table 5
Comparison of differential diagnostic ability (combination)
 
Sensitivity
Specificity
Accuracy
(1) and (2)
0.89
0.81
0.84
(1) and (3)
0.79
0.83
0.81
(2) and (3)
0.75
0.62
0.67
(1) CIScore, (2) Z score of MTL, (3) atrophic ratio
Table 6
Comparison of differential diagnostic ability (combination, excluding the elderly)
 
Sensitivity
Specificity
Accuracy
(1) and (2)
1
0.9
0.94
(1) and (3)
1
0.85
0.90
(2) and (3)
1
0.5
0.68
(1) CIScore, (2) Z score of MTL, (3) atrophic ratio
The accuracy of the combination with CIScore and Z score value of MTL was 84%, which was higher than other parameters, and significantly higher than DBS alone (Fig. 1). When we adopted them confined to ages younger than 75 years old, the accuracy improved to 94%. This result was significantly higher than other parameters (single or combination) (Fig. 2). As for DBS, we also analyzed using white matter, the diagnostic accuracy by atrophic ratio of Z score (DBS/MTL) was lower than using gray matter. And diagnostic accuracy in each combination using DBS (white matter) was lower than those in the combination of CIScore and Z score of MTL, in both all the cases and in the group excluding elderly cases (Online Resource 1, 2).

Cases

Case1 (Fig. 3). Seventy-five-year-old male diagnosed as DLBs. Insomnia was noted 8 years ago and parkinsonism with dementia from 3 years ago. The dementia level at hospitalization was MMSE 13/30. Both 99mTc-ECD SPECT and 3-dimensional T1-weighted sagittal images were undertaken at hospitalized. The rCBF SPECT using eZIS analysis showed significant hypo-perfusion in the bilateral occipital lobe and the CIScore was 0.11, which was true positive diagnosing DLB. The Z score using VSRAD was true positive at 1.39, but Atrophy ratio was false negative at 0.27. This case was correctly diagnosed as DLB by the combination of CIScore and Z score.
Case2 (Fig. 4). Eighty-three years old female with AD. Both mild dementia and pathological jealousy from 2 years ago were noted. The value of MMSE was 22/30. 99mTc-ECD SPECT and 3-dimensional T1-weighted sagittal images were undertaken. The rCBF SPECT with eZIS analysis demonstrated that significant hypo-perfusion in the posterior-cingulate gyrus, and the value of CIScore was 1.24, which was a true negative. The Z score by VSRAD was 1.63, and Atrophy ratio was 0.46, both indexes showed false positive. Although we could diagnose as AD by CIScore, MRI parameters alone misdiagnosed.
Case3 (Fig. 5). Sixty-seven years old female with DLB. She has been treated for depression for several years. Both cognitive dysfunction and visual hallucination were noted from one year ago. The dementia scale was 20/30 in MMSE and was diagnosed with DLBs. 99mTc-ECD SPECT using eZIS analysis showed that significant hypo-perfusion in the bilateral occipital lobe, and the value of CIScore was 0.11 within true positive values for DLB. As for MRI indexes using VSRAD, Z score of hippocampus was 1.53 and the atrophy ratio was 0.46, both indicated being DLB. Thus, the case was younger than 75 years old, and all parameters were true positive.

Discussion

Both DLB and AD are common cause of dementia among the elderly populations [2]. Because of some overlaps between the two disorders in clinical characteristics and imaging features, the differential diagnosis by the combined methods would be recommended. For instances, dopamine transporter (DAT)–SPECT [18] or [123I]-metaiodobenzylguanidine (MIBG) scintigraphy [2] should be useful. AS DLB has commonly dopaminergic dysfunction and DAT SPECT shows decreased uptake of I-123 ioflupane in bilateral basal ganglia. MIBG can detect the cardiac denervation that is one of the main characteristics of DLB [19]. MRI is a valuable tool for both the diagnosis and the research of AD. Because AD is a neurodegenerative condition characterized by the gradual loss of nerve cells and changes in brain tissue, MRI plays a crucial role in non-invasively visualizing these changes [20]. Using MRI, we can assess of atrophy in specific brain areas, which is the shrinkage or loss of brain tissues. Patients with AD often exhibit progressive shrinkage particular in MTL, making it a distinctive hallmark of the disease [10, 21]. There is significantly more atrophy in DBS of DLB patients, compared to AD patients [10]. MRI can capture these changes, and it can also detect other disease, such as the infarction.
The study aimed to assess the diagnostic ability of various parameters, including the CIScore derived from rCBF SPECT and the Z score for MTL atrophy from MRI, in differentiating between DLB and AD. In addition, the study also evaluated the effect of age on the diagnostic accuracy. The accuracy of the combination with CIScore and Z score value of MTL was 84%, which was higher than other parameters, and significantly higher than DBS alone. Confined to ages younger than 75 years old, the accuracy improved to 94%. It was statistically significantly higher than other parameters (single or combination).
There are a lot of VBM investigations regarding gray matter volume changes with aging [2224]. Most cortical regions remarkably in frontal and insular areas are known to show a linear negative association between volume and age [2224]. In contrast, the preservation of gray matter volume in the specific structures such as amygdala, hippocampus, and thalamus are reported in many papers [2224]. However, some degree of overlap of regional volume changes between normal aging and AD may not be avoided inevitably in the cross-sectional studies [25]. The diagnostic ability of CIScore is better in the conditions without influence of brain atrophy by aging [13].
Therefore, the diagnostic ability in both CIScore and VSRAD are affected to an extent by the brain atrophy with normal aging. Due to such backgrounds, the differential diagnostic capability by the combination with CIScore and Z score value of MTL could have been improved in the relatively younger cases such as under 75 years old in the present study.
As for the diagnostic accuracy of DBS, it was around 65% same as previous studies [26]. They also showed similar results as in Z score of MTL. However, the combined use of DBS and CIScore improved accuracy in cases under 75 years old. The result also indicated that combination of MRI and SPECT is useful in the differential diagnosis between DLB and AD younger than 75 years old.
The limitation of the present study is that the number of analyzed cases is small and the study in one institute. Future studies should be prospectively done including clinically equivocal cases by following up continuously in multi centers. In addition, Amyloid PET has come to be used for clinical settings in these days in Japan. Even in the cases of clinical diagnosis were AD, some cases were reported to be negative for Amyloid PET. Therefore, clinical diagnoses might not always be done accurately [27]. The future SPECT study regarding AD might be preferable analyzed in cases confirmed by Amyloid PET.

Conclusion

The combination of CIScore and Z score of MTL was suggested to be useful in the differential diagnosis between DLB and AD, especially, younger than 75 years old.

Declarations

Ethics approval

All procedures performed in studies involving human participants were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent was waived by the Institutional Review Board for this retrospective study.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Radiologie

Kombi-Abonnement

Mit e.Med Radiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Radiologie, den Premium-Inhalten der radiologischen Fachzeitschriften, inklusive einer gedruckten Radiologie-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863–72.CrossRefPubMed McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863–72.CrossRefPubMed
2.
Zurück zum Zitat McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88–100.CrossRefPubMedPubMedCentral McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88–100.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Chiaravalloti A, Barbagallo G, Ricci M, Martorana A, Ursini F, Sannino P, Karalis G, Schillaci O. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer’s disease patients: a CSF and FDG PET study. Brain Res. 2018;1678:116–22.CrossRefPubMed Chiaravalloti A, Barbagallo G, Ricci M, Martorana A, Ursini F, Sannino P, Karalis G, Schillaci O. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer’s disease patients: a CSF and FDG PET study. Brain Res. 2018;1678:116–22.CrossRefPubMed
4.
Zurück zum Zitat Rice L, Bisdas S. The diagnostic value of FDG and amyloid PET in Alzheimer’s disease-a systematic review. Eur J Radiol. 2017;94:16–24.CrossRefPubMed Rice L, Bisdas S. The diagnostic value of FDG and amyloid PET in Alzheimer’s disease-a systematic review. Eur J Radiol. 2017;94:16–24.CrossRefPubMed
5.
Zurück zum Zitat Rabinovici GD, Gatsonis C, Apgar C, Chaudhary K, Gareen I, Hanna L, Hendrix J, Hillner BE, Olson C, Lesman-Segev OH, et al. Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia. JAMA. 2019;321(13):1286–94.CrossRefPubMedPubMedCentral Rabinovici GD, Gatsonis C, Apgar C, Chaudhary K, Gareen I, Hanna L, Hendrix J, Hillner BE, Olson C, Lesman-Segev OH, et al. Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia. JAMA. 2019;321(13):1286–94.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer’s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol. 2001;50(3):358–65.CrossRefPubMed Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer’s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol. 2001;50(3):358–65.CrossRefPubMed
8.
Zurück zum Zitat Ohnishi T, Hoshi H, Nagamachi S, Jinnouchi S, Flores LG 2nd, Futami S, Watanabe K. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med. 1995;36(7):1163–9.PubMed Ohnishi T, Hoshi H, Nagamachi S, Jinnouchi S, Flores LG 2nd, Futami S, Watanabe K. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med. 1995;36(7):1163–9.PubMed
9.
Zurück zum Zitat Imabayashi E, Matsuda H, Asada T, Ohnishi T, Sakamoto S, Nakano S, Inoue T. Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer’s disease from controls using brain perfusion SPECT. J Nucl Med. 2004;45(9):1450–7.PubMed Imabayashi E, Matsuda H, Asada T, Ohnishi T, Sakamoto S, Nakano S, Inoue T. Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer’s disease from controls using brain perfusion SPECT. J Nucl Med. 2004;45(9):1450–7.PubMed
10.
Zurück zum Zitat Matsuda H, Yokoyama K, Sato N, Ito K, Nemoto K, Oba H, Hanyu H, Kanetaka H, Mizumura S, Kitamura S. Differentiation between dementia With Lewy bodies and Alzheimer’s disease using voxel-based morphometry of structural MRI: a multicenter study. Neuropsychiatr Dis Treat. 2019;15:2715–22.CrossRefPubMedPubMedCentral Matsuda H, Yokoyama K, Sato N, Ito K, Nemoto K, Oba H, Hanyu H, Kanetaka H, Mizumura S, Kitamura S. Differentiation between dementia With Lewy bodies and Alzheimer’s disease using voxel-based morphometry of structural MRI: a multicenter study. Neuropsychiatr Dis Treat. 2019;15:2715–22.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Imabayashi E, Soma T, Sone D, Tsukamoto T, Kimura Y, Sato N, Murata M, Matsuda H. Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer’s disease using brain perfusion SPECT. Ann Nucl Med. 2017;31(7):536–43.CrossRefPubMedPubMedCentral Imabayashi E, Soma T, Sone D, Tsukamoto T, Kimura Y, Sato N, Murata M, Matsuda H. Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer’s disease using brain perfusion SPECT. Ann Nucl Med. 2017;31(7):536–43.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Imabayashi E, Yokoyama K, Tsukamoto T, Sone D, Sumida K, Kimura Y, Sato N, Murata M, Matsuda H. The cingulate island sign within early Alzheimer’s disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer’s disease from dementia with Lewy bodies. EJNMMI Res. 2016;6(1):67.CrossRefPubMedPubMedCentral Imabayashi E, Yokoyama K, Tsukamoto T, Sone D, Sumida K, Kimura Y, Sato N, Murata M, Matsuda H. The cingulate island sign within early Alzheimer’s disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer’s disease from dementia with Lewy bodies. EJNMMI Res. 2016;6(1):67.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Yamaguchi Y, Ouma S, Nonokuma M, Nagamachi S, Tsuboi Y. Sensitivity and specificity of combined use of Ala score and CIScore in the diagnosis of dementia with Lewy bodies. Rinsho Shinkeigaku. 2020;60(6):407–13.CrossRefPubMed Yamaguchi Y, Ouma S, Nonokuma M, Nagamachi S, Tsuboi Y. Sensitivity and specificity of combined use of Ala score and CIScore in the diagnosis of dementia with Lewy bodies. Rinsho Shinkeigaku. 2020;60(6):407–13.CrossRefPubMed
14.
Zurück zum Zitat Graff-Radford J, Murray ME, Lowe VJ, Boeve BF, Ferman TJ, Przybelski SA, Lesnick TG, Senjem ML, Gunter JL, Smith GE, et al. Dementia with Lewy bodies: basis of cingulate island sign. Neurology. 2014;83(9):801–9.CrossRefPubMedPubMedCentral Graff-Radford J, Murray ME, Lowe VJ, Boeve BF, Ferman TJ, Przybelski SA, Lesnick TG, Senjem ML, Gunter JL, Smith GE, et al. Dementia with Lewy bodies: basis of cingulate island sign. Neurology. 2014;83(9):801–9.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging Alzheimerʼs Association workgroups on diagnostic guidelines for Alzheimerʼs disease. Alzheimers Dement. 2011;7:263–9.CrossRefPubMed McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging Alzheimerʼs Association workgroups on diagnostic guidelines for Alzheimerʼs disease. Alzheimers Dement. 2011;7:263–9.CrossRefPubMed
16.
Zurück zum Zitat Takeuchi R, Sengoku T, Matsumura K. Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT. Radiat Med. 2006;24(7):538–44.CrossRefPubMed Takeuchi R, Sengoku T, Matsumura K. Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT. Radiat Med. 2006;24(7):538–44.CrossRefPubMed
17.
Zurück zum Zitat Matsuda H, Mizumura S, Nemoto K, Yamashita F, Imabayashi E, Sato N, Asada T. Automatic voxel-based morphometry of structural MRI by SPM8 plus diffeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer disease. Am J Neuroradiol. 2012;33(6):1109–14.CrossRefPubMedPubMedCentral Matsuda H, Mizumura S, Nemoto K, Yamashita F, Imabayashi E, Sato N, Asada T. Automatic voxel-based morphometry of structural MRI by SPM8 plus diffeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer disease. Am J Neuroradiol. 2012;33(6):1109–14.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Brigo F, Turri G, Tinazzi M. 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias. J Neurol Sci. 2015;359(1–2):161–71.CrossRefPubMed Brigo F, Turri G, Tinazzi M. 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias. J Neurol Sci. 2015;359(1–2):161–71.CrossRefPubMed
19.
Zurück zum Zitat Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, Yoshita M. Diagnostic criteria for dementia with Lewy bodies: updates and future directions. J Mov Disord. 2020;13(1):1–10.CrossRefPubMed Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, Yoshita M. Diagnostic criteria for dementia with Lewy bodies: updates and future directions. J Mov Disord. 2020;13(1):1–10.CrossRefPubMed
20.
Zurück zum Zitat Harrington CR. The molecular pathology of Alzheimer’s disease. Neuroimaging Clin N Am. 2012;22:11–22.CrossRefPubMed Harrington CR. The molecular pathology of Alzheimer’s disease. Neuroimaging Clin N Am. 2012;22:11–22.CrossRefPubMed
21.
Zurück zum Zitat Matsuda H. Voxel-based morphometry of brain MRI in normal aging and Alzheimer’s disease. Aging Dis. 2013;4(1):29–37.PubMed Matsuda H. Voxel-based morphometry of brain MRI in normal aging and Alzheimer’s disease. Aging Dis. 2013;4(1):29–37.PubMed
22.
Zurück zum Zitat Matsuda H, Ohnishi T, Asada T, Li ZJ, Kanetaka H, Imabayashi E, et al. Correction for partial-volume effects on brain perfusion SPECT in healthy men. J Nucl Med. 2003;44:1243–52.PubMed Matsuda H, Ohnishi T, Asada T, Li ZJ, Kanetaka H, Imabayashi E, et al. Correction for partial-volume effects on brain perfusion SPECT in healthy men. J Nucl Med. 2003;44:1243–52.PubMed
23.
Zurück zum Zitat Grieve SM, Clark CR, Williams LM, Peduto AJ, Gordon E. Preservation of limbic and paralimbic structures in aging. Hum Brain Mapp. 2005;25:391–401.CrossRefPubMedPubMedCentral Grieve SM, Clark CR, Williams LM, Peduto AJ, Gordon E. Preservation of limbic and paralimbic structures in aging. Hum Brain Mapp. 2005;25:391–401.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Terribilli D, Schaufelberger MS, Duran FL, Zanetti MV, Curiati PK, Menezes PR, et al. Age-related gray matter volume changes in the brain during non-elderly adulthood. Neurobiol Aging. 2011;32:354–68.CrossRefPubMedPubMedCentral Terribilli D, Schaufelberger MS, Duran FL, Zanetti MV, Curiati PK, Menezes PR, et al. Age-related gray matter volume changes in the brain during non-elderly adulthood. Neurobiol Aging. 2011;32:354–68.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Kantarci K, Ferman T, Bradley F, Stephen D, Przybelski S. Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. Neurology. 2012;79(6):553–60.CrossRefPubMedPubMedCentral Kantarci K, Ferman T, Bradley F, Stephen D, Przybelski S. Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. Neurology. 2012;79(6):553–60.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Akamatsu G, Ikari Y, Ohnishi A, Matsumoto K, Nishida H, Yamamoto Y, et al. Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study. EJNMMI Res. 2019;9(1):91.CrossRefPubMedPubMedCentral Akamatsu G, Ikari Y, Ohnishi A, Matsumoto K, Nishida H, Yamamoto Y, et al. Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study. EJNMMI Res. 2019;9(1):91.CrossRefPubMedPubMedCentral
Metadaten
Titel
The usefulness of combined analysis using CIScore and VSRAD parameters for differentiating between dementia with Lewy body and Alzheimer’s disease
verfasst von
Gaku Honda
Shigeki Nagamachi
Mai Takahashi
Yukie Higuma
Tomonobu Tani
Kosuke Hida
Kengo Yoshimitsu
Koji Ogomori
Yoshio Tsuboi
Publikationsdatum
10.06.2024
Verlag
Springer Nature Singapore
Erschienen in
Japanese Journal of Radiology / Ausgabe 10/2024
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-024-01604-5

Neu im Fachgebiet Radiologie

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Stören weiße Wände und viel Licht die Bildqualitätskontrolle?

Wenn es darum geht, die technische Qualität eines Mammogramms zu beurteilen, könnten graue Wandfarbe und reduzierte Beleuchtung im Bildgebungsraum von Vorteil sein. Darauf deuten zumindest Ergebnisse einer kleinen Studie hin. 

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.